CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Ferring against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Safe Desmopressin AdministrationALLERGANAug 20, 2020
Use Of N-Acetyl-5-Methoxytryptamine Or Analogues Thereof, For Promoting The Mechanism Of Implantation Of The Embryo And Related Compositions And Culture MediaARES TRADINGMay 14, 2019
Safe Desmopressin AdministrationACERUS PHARMACEUTICALS USAMay 1, 2019
The Puro-Dhfr Quadrifunctional Marker And Its Use In Protein ProductionMERCK SERONOSep 4, 2018
Safe Desmopressin AdministrationACERUS PHARMACEUTICALS USAMar 12, 2018

Explore Ferring's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jul 10, 2024Manufacture Of Degarelix4
Mar 13, 2024Topical Pharmaceutical Composition For Treatment Of Anal Fissures And Hemorrhoids1
Nov 3, 2021Pharmaceutical Composition1
Sep 23, 2020Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation1
Aug 7, 2019Unitary Combination Of Fsh And Hcg1
Jul 5, 2017Composition For The Treatment Of Prostate Cancer1
Mar 29, 2017Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation1

Top competitors of Ferring

List of top competitors of Ferring based on patent oppositions.